Meet the six startups in second cohort of GE Healthcare India accelerator

Meet the six startups in second cohort of GE Healthcare India accelerator
21 Dec, 2020

Chicago, Illinois headquartered GE Healthcare has launched the second cohort of its India startup collaboration programme.

The six healthtech startups chosen for the India Edison Accelerator will be mentored and offered strategic partnerships to co-develop healthcare solutions with GE’s engineers and scientists, a statement said.

The second edition of the programme focuses on technology solutions aimed at streamlining healthcare delivery across verticals, such as advanced imaging and visualisation, precision diagnosis and treatment, computer-aided detection and diagnosis, point-of-care diagnostics, remote patient monitoring, virtual hospitals, data management and insights, and asset health monitoring.

“The aim of this programme is to harness the brainpower of the startup ecosystem to develop solutions on the Edison platform for some of the toughest healthcare challenges existing today. We are excited about the second cohort of ‘India EdisonTM Accelerator – startups powered by GE Healthcare’ and the collaboration that we are already seeing between the startup community, our colleagues and the Edison platform itself,” Girish Raghavan, vice president of software engineering at GE Healthcare South Asia, said.

The programme will offer a zero-equity cash-in-grant of $10000 (Rs 7.3 lakh) to each startup, along with access to mentorship, skill development opportunities, commercial and regulatory guidance, as well as data provision.

The startups can leverage the Edison platform and collaborate with GE Healthcare to create solutions that improve patient outcomes and experience, efficiency of clinical practice and that of the healthcare facilities, reduce waste and inefficiencies, and eliminate costly and harmful errors.

Edison is an advanced intelligence offering used by GE Healthcare’s internal developers and strategic partners to develop new healthcare applications, services and AI algorithms. It comprises applications, smart devices and the Edison platform. According to the company, over 100 applications are currently available on the Edison platform.

In June, five startups -- 5C Network, DeepTek, Orbo, Predible and Synapsica -- graduated from the first batch of the programme.

A quick look at the startups in the second cohort:

AarogyaAI:  Founded in 2019, New Delhi-based AarogyaAI enables quick and accurate diagnosis of drug-resistant tuberculosis (DR-TB) to help physicians instantly prescribe effective drug combinations for treatment. The artificial intelligence (AI)-enabled software as a service (SaaS) startup was also part of MeitY’s StartupToScaleup programme.

BrainSightAI: Bengaluru headquartered BrainSightAI is building an MRI-based SaaS platform to enable greater precision in neurological and psychiatric investigation. Backed by Entrepreneur First, the startup was part of accelerator programmes by Dassault and NetApp.

Fluid AI: Mumbai-based Fluid AI offers AI-based interactive experiences, and data analytics and predictions for businesses.

InMed Prognostics: Based in Pune, InMed Prognostics offers an AI and machine learning (ML)-based MRI tool to neuro radiologists, neuro physicians and psychiatrists. Its flagship product Neuroshield integrates MRI images, clinical reports and psychological assessments to produce automated, quantified reports to support the physician’s clinical impression for various neurological disorders.

Wellthy Therapeutics: The startup provides an AI-based disease management platform to help patients manage chronic conditions better. The Mumbai-based company is backed by drugmaker Cipla, venture capital firms Saama Capital, GrowX Ventures and Design Capital Ventures, and the family office of Ranjan Pai, chairman of Manipal Education and Medical Group.

Onward Assist: Hyderabad-based Onward Assist is an advanced cancer prognostics platform for histopathologists and radiologists. It builds machine learning models to support decision making and improve outcomes.

Comment(s)